What an online consultation with NMT looks like
An online consultation is a formal scheduled meeting — held online — between a senior consultant and the patient, together with any family members or caregivers the patient wishes to include. Most consultations are conducted by Dr. Ishita B. Sen; on dates when she is not available, the consultation may be conducted by her colleague Dr. Dharmender Malik. Either way, you'll be in senior hands. The session runs for 20 minutes over a secure video link.
To make the discussion meaningful, we ask that the patient's medical records be uploaded at least 24 hours before the call — the imaging report, pathology, prior treatment notes, recent biochemistry, and a brief clinical history. The consultant reviews these in advance, so by the time you join the call, the case is already understood.
One practical suggestion: write down the questions you want to ask, and bring the list with you. Patients who arrive with a clear set of questions get noticeably more out of the 20 minutes — it is the most efficient way to use the time, and the conversation can stay focused on what matters to you.
A note on rescheduling
Our consultants are practising clinicians at FMRI Gurugram, with a department that runs live every working day. In rare cases — almost always a clinical emergency — your scheduled online consultation may need to be moved.
What this means for you
We will endeavour to give you as much notice as we possibly can if a reschedule becomes necessary, and to offer you the next available slot at a time that suits you. By the nature of clinical emergencies, however, the change may sometimes come at short notice — occasionally on the day of the call itself. We're grateful for your understanding when this happens. There is no additional fee for a reschedule initiated by us; your slot will simply be re-booked at the earliest mutual convenience.
If you need to request a reschedule, please email info@nuclearmedicinetherapy.in or message our administrator on WhatsApp at +91 8800988936 (chat only — please mention the patient's name).
What we can help you with
Theranostics is a specialised field of nuclear oncology — a class of targeted radiopharmaceutical therapies for cancers that have not responded fully to surgery, chemotherapy, or radiation, or that have returned after first-line treatment. Dr. Sen has spent two decades treating patients with these therapies, with a particular focus on the next-generation protocols that are reshaping outcomes in difficult-to-treat cancers.
Flagship: Actinium-225 alpha therapy
Alpha-emitter therapy with Actinium-225 PSMA for advanced prostate cancer, and Alpha PRRT (Ac-225 DOTATATE) for neuroendocrine tumours, is the most significant advance in radiopharmaceutical oncology of the last decade — and one of the most clinically demanding to deliver well. Alpha particles carry roughly a thousand times the cell-killing energy of beta particles, with a much shorter range, which means they can be highly effective in patients who have progressed despite Lu-177 therapy. Dr. Sen led the country's first Alpha PSMA programme, built and refined the protocols in use at FMRI, and is the reference clinician for several other Indian and South Asian centres now offering alpha therapies. If you or a family member is exploring this option, the consultation is the right starting point.
Flagship: Terbium-161 — the next generation of PRRT
Terbium-161 is a newer radioisotope being deployed for neuroendocrine tumours and emerging indications. Compared with Lu-177, Tb-161 emits additional Auger and conversion electrons that are particularly effective against micrometastatic disease and small-volume residual tumour — the disease burden that beta-emitters often leave behind. Very few centres in India are equipped to deliver Tb-161 therapy. The consultation is an opportunity to discuss whether this is appropriate for your situation, what response looks like, and how it fits within an overall treatment plan.
The full theranostic continuum at FMRI
Alongside the flagship alpha and Tb-161 protocols, we deliver the established beta-emitter therapies: Lutetium-177 PSMA for advanced prostate cancer, Lu-177 DOTATATE (PRRT) for neuroendocrine tumours, I-131 for differentiated and refractory thyroid cancers, I-131 MIBG for paediatric neuroblastoma and selected adult tumours, and TARE (Y-90) for liver tumours. Patients are sequenced across these therapies based on disease stage, prior treatment, and response — and a 20-minute consultation is often where that sequencing first gets discussed.
Cancers we treat
The team's primary clinical focus is on patients with advanced prostate cancer, neuroendocrine tumours of the gut, pancreas, and lung, differentiated and refractory thyroid cancers, paediatric and adult neuroblastoma, and liver tumours suitable for selective internal radiation. If you or your loved one has been diagnosed with any of these — whether newly, or in a setting where standard treatment is no longer holding the disease — there is likely something we can offer or discuss.
Between cycles — staying on track
Patients already on a theranostic protocol use the consultation to discuss response between cycles, side-effect management (haematological recovery, salivary gland protection, renal function), scheduling, and whether to continue, pause, or shift the protocol. For patients whose treatment was started at FMRI and who live elsewhere in India, this is the simplest way to stay closely connected to the treating team without travelling for each review.
A second senior view — for the family that wants to be sure
If a treatment plan has already been proposed elsewhere, a 20-minute meeting with Dr. Sen gives the patient and family a senior, independent view from one of India's most experienced theranostic physicians. The conversation typically covers candidacy, realistic outcomes, side-effect profile, what to ask the treating team, and what would be different — if anything — about how the protocol would be run at FMRI.
Meet your specialists
Online consultations are conducted by senior nuclear medicine consultants. Most consultations are taken by Dr. Sen; on dates when she is not available, Dr. Malik conducts the session. The administrator will discuss any preference with you when scheduling.
IS
Director · Head of Practice
Dr. Ishita B. Sen
Head, Department of Nuclear Medicine & Molecular Imaging, Fortis Memorial Research Institute (FMRI), Gurugram — since the department's inception.
- 22+ years in nuclear medicine · 60+ peer-reviewed publications
- MD (Nuclear Medicine), AIIMS · Fellowship, University of Pennsylvania
- First physician in India to deliver Alpha PSMA therapy
- International faculty; reviewer for peer-reviewed nuclear medicine journals
DM
Senior Consultant
Dr. Dharmender Malik
Senior Consultant, Department of Nuclear Medicine and Theranostics, Fortis Memorial Research Institute, Gurugram.
- Sub-specialty interest in PSMA and DOTATATE theranostics
- Response assessment and dosimetry-guided therapy
- Active in clinical research and oncologic PET-CT
- Registered with relevant State Medical Council
Both specialists are registered with the relevant State Medical Council and operate under the NMC Telemedicine Practice Guidelines, 2020 for online consultations with patients in India.
Fee & turnaround
- Consultation fee: ₹ 2,500 per consult (20-minute session).
- What's included: the live video / voice meeting with the consultant (having reviewed the patient's records ahead of the call), and a structured written summary including any prescription, delivered by secure email afterwards.
- Written summary & prescription: delivered within 24 hours of the consult, except on Sundays and Public Holidays — when delivery may extend to the next working day.
- Payment & slot allocation: the fee is collected through a secure payment gateway, and once payment is confirmed, your consultation slot is formally allotted and locked in.
If the consultation cannot proceed for technical reasons attributable to us, the slot is rescheduled at no additional cost; if rescheduling is not acceptable, the fee is refunded (less the payment-gateway transaction fee, which is borne by the patient). Full refund and rescheduling terms are set out in the Online Consultation Terms & Conditions.
Privacy, data & recording policy
- Your medical records (reports, history, identity card) are uploaded to a secure, access-controlled folder. Access is limited to the consulting specialist and the TPPL administrator handling your case.
- Sessions run on an end-to-end encrypted video platform (typically Google Meet, with WhatsApp video or audio as fallback). Consultations are never recorded — neither audio nor video. No consent-based exception, no exceptions for teaching. The consultation belongs to the patient.
- Records are retained on our primary server for 14 days after the consultation, then deleted. Please note that third-party data-storage providers (such as AWS and others) may retain backup copies for longer periods in line with their own retention and disaster-recovery policies, over which we have only limited control.
- We do not share your data with third parties for marketing. Anonymised case material may, with your separate written consent, be used in academic teaching.
Accuracy is your responsibility
The consultation is based entirely on the records and information you submit. Please ensure all uploaded documents are correct, current, and belong to the patient named in the form. Inaccurate, outdated, or incomplete records can lead to inappropriate guidance — and the responsibility for the accuracy of submitted data sits with the patient or the person submitting the form.
Submitting your enquiry
The enquiry process has been designed so that the patient is matched to the right service — online consultation or in-person OPD — and so that Dr. Sen's time is reserved for cases that are clinically ready to be discussed.
i
You submit the enquiry form
Fill in the patient's details, upload the records, identity card, and previous scan reports, and indicate whether you'd prefer an online consultation or an in-person appointment at FMRI Gurugram.
ii
The TPPL administrator reviews the submission
The administrator checks that the records are complete and clinically sufficient. If anything is missing or unclear, they will contact you by email or via your patient dashboard to request the additional information. Please respond promptly — incomplete cases cannot be progressed to the consultant.
iii
You confirm the records are accurate and complete
Before the case is forwarded to Dr. Sen or Dr. Malik, you will be asked to confirm — in writing — that the records you have submitted are correct, current, and belong to the named patient. The clinical guidance you receive depends entirely on this confirmation.
iv
The consultant reviews and a slot is offered
For online cases, the administrator schedules the 20-minute video session at a time that works for you and the consultant. For in-person cases, the administrator facilitates an OPD appointment with Dr. Sen or Dr. Malik at Fortis Memorial Research Institute, Sector 44, Gurugram.